Skip to content

Development and Implementation of Pharmacist-based Diabetic Intervention Model in type-2 diabetes patients in Pakistan: A randomized controlled trial

Development and Implementation of Pharmacist-based Diabetic Intervention Model for patients with type-2 diabetes in Pakistan and impact on Glycated Hemoglobin: A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12619001618145
Acronym
PDIM
Enrollment
110
Registered
2019-11-22
Start date
2019-09-23
Completion date
2019-09-30
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The study is designed as prospective, randomized controlled trial. In this study, around 110 patients shall be screened and allocated into groups based upon block randomization method. Pre- and Post-Intervention data from subjects shall be recorded on prestructured data collection form and the time between these two points shall be of 6 months. Intervention includes education about disease and treatment. The impact of this intervention on HbA1C and the secondary outcomes like BMI, visceral fats and body fats shall be determined.

Interventions

Around 110 patients will be taken. They will be block randomized into control and intervention group Pharmacist-based Diabetic Intervention Model (PDIM) includes "Diabetes Educational Module (booklet in both english and local language urdu)", "Medication Adherence improvement strategies" and "tele-pharmacy services" that will be delivered by a Pharmacist, 4 times in a month, at community pharmacy setup. "Diabetes Educational Module" consists of a booklet that shall be provided to the patient fo

Around 110 patients will be taken. They will be block randomized into control and intervention group Pharmacist-based Diabetic Intervention Model (PDIM) includes "Diabetes Educational Module (booklet in both english and local language urdu)", "Medication Adherence improvement strategies" and "tele-pharmacy services" that will be delivered by a Pharmacist, 4 times in a month, at community pharmacy setup. "Diabetes Educational Module" consists of a booklet that shall be provided to the patient for disease knowledge improvement. This booklet is specifically designed. Medication improvement adherence strategies shall involve a well designed way of counselling patients, providing drug information by tele-pharmacy services. Subject health, adherence and other self care practice that patient is adopting can be assessed by telephone services for the purpose of follow-up.

Sponsors

Tauqeer Hussain
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

Type-2 diabetes mellitus

Exclusion criteria

Pregnancy Juvenile Type Diabetes Type-1 diabetes Dementia

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026